, trigger rapid signaling events linked to neuronal hyperactivity in human neurons, and indicate PLC-γ1 as a potential therapeutic target.
Share your take
Add a clinician perspective alongside expert commentary.
Ojeda-Juárez et al. (2026) studied this question.